Amos Song1, Joshua DeClercq1, Gregory D Ayers1, Laurence D Higgins2, John E Kuhn1, Keith M Baumgarten3, Elizabeth Matzkin4, Nitin B Jain1. 1. Departments of Physical Medicine and Rehabilitation (A.S. and N.B.J.), Orthopaedics and Rehabilitation (N.B.J. and J.E.K.), and Biostatistics (J.D. and G.D.A.), Vanderbilt University Medical Center, Nashville, Tennessee. 2. King Edward Memorial Hospital, Hamilton, Bermuda. 3. Orthopedic Institute of Sioux Falls, Sioux Falls, South Dakota. 4. Department of Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Comparative time to recovery after operative and nonoperative treatment for rotator cuff tears is an important consideration for patients. Hence, we compared the time to achieve clinically meaningful reduction in shoulder pain and function after treatment. METHODS: From February 2011 to June 2015, a multicenter cohort of patients with rotator cuff tears undergoing operative or nonoperative treatment was recruited. After propensity score weighting, the Kaplan-Meier method was used to estimate the time to achieve a minimal clinically important difference (MCID), >30% reduction, and >50% reduction in the Shoulder Pain and Disability Index (SPADI) and the American Shoulder and Elbow Surgeons (ASES) scores. (In our analysis, both ASES and SPADI were coded such that a lower number corresponded to a better outcome; thus, the word "reduction" was used to indicate improvement in both ASES and SPADI scores.) A 2-stage test was conducted to detect a difference between the 2 groups. RESULTS: In this cohort, 96 patients underwent nonoperative treatment and 73 patients underwent a surgical procedure. The surgical treatment group and the nonoperative treatment group were significantly different with respect to SPADI and ASES scores (p < 0.05). The maximum difference between groups in achievement of the MCID for the SPADI scores was at 3.25 months, favoring the nonoperative treatment group. The probability to achieve the MCID was 0.06 (95% confidence interval [CI], 0.00 to 0.12) for the surgical treatment group compared with 0.40 (95% CI, 0.29 to 0.50) for the nonoperative treatment group. The surgical treatment group had a greater probability of achieving >50% reduction in SPADI scores at 15.49 months (0.20 [95% CI, 0.12 to 0.29] for the surgical treatment group compared with 0.04 [95% CI, 0.00 to 0.09] for the nonoperative treatment group). The surgical treatment group had a greater probability of achieving >50% reduction in ASES scores at 24.74 months (0.96 [95% CI, 0.84 to 0.99] for the surgical treatment group compared with 0.66 [95% CI, 0.53 to 0.75] for the nonoperative treatment group). The differences for >30% reduction in SPADI and ASES scores and the MCID for ASES scores were not significant. CONCLUSIONS: Patients undergoing nonoperative treatment had significantly better outcomes in the initial follow-up period compared with patients undergoing a surgical procedure, but this trend reversed in the longer term. These data can be used to inform expectations for nonoperative and operative treatments for rotator cuff tears. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
BACKGROUND: Comparative time to recovery after operative and nonoperative treatment for rotator cuff tears is an important consideration for patients. Hence, we compared the time to achieve clinically meaningful reduction in shoulder pain and function after treatment. METHODS: From February 2011 to June 2015, a multicenter cohort of patients with rotator cuff tears undergoing operative or nonoperative treatment was recruited. After propensity score weighting, the Kaplan-Meier method was used to estimate the time to achieve a minimal clinically important difference (MCID), >30% reduction, and >50% reduction in the Shoulder Pain and Disability Index (SPADI) and the American Shoulder and Elbow Surgeons (ASES) scores. (In our analysis, both ASES and SPADI were coded such that a lower number corresponded to a better outcome; thus, the word "reduction" was used to indicate improvement in both ASES and SPADI scores.) A 2-stage test was conducted to detect a difference between the 2 groups. RESULTS: In this cohort, 96 patients underwent nonoperative treatment and 73 patients underwent a surgical procedure. The surgical treatment group and the nonoperative treatment group were significantly different with respect to SPADI and ASES scores (p < 0.05). The maximum difference between groups in achievement of the MCID for the SPADI scores was at 3.25 months, favoring the nonoperative treatment group. The probability to achieve the MCID was 0.06 (95% confidence interval [CI], 0.00 to 0.12) for the surgical treatment group compared with 0.40 (95% CI, 0.29 to 0.50) for the nonoperative treatment group. The surgical treatment group had a greater probability of achieving >50% reduction in SPADI scores at 15.49 months (0.20 [95% CI, 0.12 to 0.29] for the surgical treatment group compared with 0.04 [95% CI, 0.00 to 0.09] for the nonoperative treatment group). The surgical treatment group had a greater probability of achieving >50% reduction in ASES scores at 24.74 months (0.96 [95% CI, 0.84 to 0.99] for the surgical treatment group compared with 0.66 [95% CI, 0.53 to 0.75] for the nonoperative treatment group). The differences for >30% reduction in SPADI and ASES scores and the MCID for ASES scores were not significant. CONCLUSIONS: Patients undergoing nonoperative treatment had significantly better outcomes in the initial follow-up period compared with patients undergoing a surgical procedure, but this trend reversed in the longer term. These data can be used to inform expectations for nonoperative and operative treatments for rotator cuff tears. LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
Authors: J J Luime; B W Koes; I J M Hendriksen; A Burdorf; A P Verhagen; H S Miedema; J A N Verhaar Journal: Scand J Rheumatol Date: 2004 Impact factor: 3.641
Authors: Janna L Friedly; Bryan A Comstock; Judith A Turner; Patrick J Heagerty; Richard A Deyo; Sean D Sullivan; Zoya Bauer; Brian W Bresnahan; Andrew L Avins; Srdjan S Nedeljkovic; David R Nerenz; Christopher Standaert; Larry Kessler; Venu Akuthota; Thiru Annaswamy; Allen Chen; Felix Diehn; William Firtch; Frederic J Gerges; Christopher Gilligan; Harley Goldberg; David J Kennedy; Shlomo Mandel; Mark Tyburski; William Sanders; David Sibell; Matthew Smuck; Ajay Wasan; Lawrence Won; Jeffrey G Jarvik Journal: N Engl J Med Date: 2014-07-03 Impact factor: 91.245
Authors: Frederik O Lambers Heerspink; Jos J A M van Raay; Rinco C T Koorevaar; Pepijn J M van Eerden; Robin E Westerbeek; Esther van 't Riet; Inge van den Akker-Scheek; Ronald L Diercks Journal: J Shoulder Elbow Surg Date: 2015-08 Impact factor: 3.019
Authors: Austin J Ramme; Christopher B Robbins; Karan A Patel; James E Carpenter; Asheesh Bedi; Joel J Gagnier; Bruce S Miller Journal: J Bone Joint Surg Am Date: 2019-10-02 Impact factor: 5.284
Authors: John E Kuhn; Warren R Dunn; Rosemary Sanders; Qi An; Keith M Baumgarten; Julie Y Bishop; Robert H Brophy; James L Carey; Brian G Holloway; Grant L Jones; C Benjamin Ma; Robert G Marx; Eric C McCarty; Sourav K Poddar; Matthew V Smith; Edwin E Spencer; Armando F Vidal; Brian R Wolf; Rick W Wright Journal: J Shoulder Elbow Surg Date: 2013-03-27 Impact factor: 3.019
Authors: Alexis Chiang Colvin; Natalia Egorova; Alicia K Harrison; Alan Moskowitz; Evan L Flatow Journal: J Bone Joint Surg Am Date: 2012-02-01 Impact factor: 5.284
Authors: Nitin B Jain; Gregory D Ayers; Run Fan; John E Kuhn; Jon J P Warner; Keith M Baumgarten; Elizabeth Matzkin; Laurence D Higgins Journal: Am J Sports Med Date: 2019-09-13 Impact factor: 6.202